Kt/V

Global Hemodialysis and Peritoneal Dialysis Market (2020 to 2027) - by Product, Type, and End-user - ResearchAndMarkets.com

Retrieved on: 
Monday, February 22, 2021
Health, Medical Supplies, Medical devices, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Dialysis, Hemodialysis, Peritoneal dialysis, Northwest Kidney Centers, Kt/V

The "Hemodialysis and Peritoneal Dialysis Market by Product, Type, and End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis and Peritoneal Dialysis Market by Product, Type, and End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Based on the peritoneal dialysis product type, the consumables segment is estimated to account for the largest share of this market in 2020.
  • The large share of this segment is mainly attributed to the requirement of peritoneal dialysis consumables for both types of peritoneal dialysis.
  • North America is estimated to command the largest share of the hemodialysis and peritoneal dialysis market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Hemodialysis and Peritoneal Dialysis Market Worth $17.69 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®

Retrieved on: 
Tuesday, October 27, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Peritoneal dialysis, Dialysis, Hemodialysis, Peritoneum, Kt/V, Northwest Kidney Centers

In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.

Key Points: 
  • In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.
  • Due to lockdowns, the availability of consumables and equipment for hemodialysis and peritoneal dialysis and essential medicines has been affected.
  • Based on end user, hospitals, clinics, and dialysis centers are estimated to command the largest share of the overall hemodialysis and peritoneal dialysis market in 2020.
  • Geographically, North America is estimated to dominate the global hemodialysis and peritoneal dialysis market in 2020, followed by Europe and Asia-Pacific.

Hemodialysis and Peritoneal Dialysis Market Worth $17.69 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®

Retrieved on: 
Tuesday, October 27, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Peritoneal dialysis, Dialysis, Hemodialysis, Peritoneum, Kt/V, Northwest Kidney Centers

In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.

Key Points: 
  • In peritoneal dialysis, the patient's peritoneum in the abdomen acts as a membrane across which fluids and dissolved substances are exchanged from the blood.
  • Due to lockdowns, the availability of consumables and equipment for hemodialysis and peritoneal dialysis and essential medicines has been affected.
  • Based on end user, hospitals, clinics, and dialysis centers are estimated to command the largest share of the overall hemodialysis and peritoneal dialysis market in 2020.
  • Geographically, North America is estimated to dominate the global hemodialysis and peritoneal dialysis market in 2020, followed by Europe and Asia-Pacific.

World’s First Patient Starts Using Outset Medical’s Tablo Dialysis System at Home

Retrieved on: 
Monday, July 13, 2020
Medical devices, Seniors, Consumer, Health, Managed care, Medicine, Clinical medicine, Membrane technology, Renal dialysis, Nephrology, Detoxification, Dialysis, Hemodialysis, Clearance, Kt/V, the Tablo Hemodialysis System, Outset Medical

Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medicals mobile Tablo Hemodialysis System at home since it received FDA clearance on March 31.

Key Points: 
  • Fifty-seven year old dialysis patient Tracey Amadi of central New Jersey is the first person in the world to use Outset Medicals mobile Tablo Hemodialysis System at home since it received FDA clearance on March 31.
  • The four-wheel system only needs an electrical outlet and tap water connection to automatically produce dialysate required for dialysis.
  • I am thrilled to be using this amazing system at home, said Ms. Amadi.
  • Tablo is an FDA-cleared enterprise solution for dialysis, designed specifically to reduce the cost and complexity of dialysis across all care settings.

InventHelp Inventor Develops Improved Dialysis Heating Device (CBA-3670)

Retrieved on: 
Tuesday, April 21, 2020
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Dialysis, Peritoneal dialysis, Hemodialysis, Kt/V

The invention provides an effective way to warm the fluid used in peritoneal dialysis.

Key Points: 
  • The invention provides an effective way to warm the fluid used in peritoneal dialysis.
  • In doing so, it offers an improved alternative to traditional prewarming methods.
  • The invention features a simple design that is convenient and easy to use so it is ideal for individuals who utilize peritoneal dialysis.
  • "My design ensures that dialysis fluid is the correct temperature for patient comfort."

Hemodialysis and Peritoneal Dialysis Market to Grow at 6.0% CAGR to 2024 - Led by Hospitals and Dialysis Centers

Retrieved on: 
Tuesday, July 30, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Peritoneal dialysis, Nocturnal dialysis, Kt/V

The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.

Key Points: 
  • The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.
  • Hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis.
  • Hemodialysis and peritoneal dialysis market is classified into three major segmentsconventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).
  • This report analyzes industry trends, hemodialysis and peritoneal dialysis market shares of top players, and company profiles, which together forma basic view of the market.

Hemodialysis and Peritoneal Dialysis Market to Grow at 6.0% CAGR to 2024 - Led by Hospitals and Dialysis Centers

Retrieved on: 
Tuesday, July 30, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Peritoneal dialysis, Nocturnal dialysis, Kt/V

The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.

Key Points: 
  • The hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis.
  • Hemodialysis & peritoneal dialysis market is segmented into hemodialysis and peritoneal dialysis.
  • Hemodialysis and peritoneal dialysis market is classified into three major segmentsconventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis (NHD).
  • This report analyzes industry trends, hemodialysis and peritoneal dialysis market shares of top players, and company profiles, which together forma basic view of the market.

AWAK Technologies Wearable Peritoneal Dialysis Device Granted Breakthrough Device Designation by the US FDA

Retrieved on: 
Friday, January 11, 2019
Medicine, Renal dialysis, Membrane technology, Dialysis, Peritoneal dialysis, Hemodialysis, Kidney transplantation, Kidney, Home hemodialysis, Kt/V

Since renal transplantation is highly dependent on patient's health and age, dialysis scores over as the primary treatment.

Key Points: 
  • Since renal transplantation is highly dependent on patient's health and age, dialysis scores over as the primary treatment.
  • It was estimated as of 2011, there were 2.7 million ESRD patients of whom 2.1 million were on dialysis.
  • Of these 2.1 million, 10.8% of the patients are on peritoneal dialysis (PD) and the remaining 89.2% are on hemodialysis (HD)[1].
  • Dialysis treatment can be performed either at home, in a dialysis centre or at a hospital.

AWAK Technologies Wearable Peritoneal Dialysis Device Granted Breakthrough Device Designation by the US FDA

Retrieved on: 
Friday, January 11, 2019
Medicine, Renal dialysis, Membrane technology, Dialysis, Peritoneal dialysis, Hemodialysis, Kidney transplantation, Kidney, Home hemodialysis, Kt/V

Since renal transplantation is highly dependent on patient's health and age, dialysis scores over as the primary treatment.

Key Points: 
  • Since renal transplantation is highly dependent on patient's health and age, dialysis scores over as the primary treatment.
  • It was estimated as of 2011, there were 2.7 million ESRD patients of whom 2.1 million were on dialysis.
  • Of these 2.1 million, 10.8% of the patients are on peritoneal dialysis (PD) and the remaining 89.2% are on hemodialysis (HD)[1].
  • Dialysis treatment can be performed either at home, in a dialysis centre or at a hospital.

Baxter Starts U.S. Clinical Trial for on-Demand Peritoneal Dialysis Solution System

Retrieved on: 
Monday, January 7, 2019
Surgery, Health, Clinical trials, Hospitals, Medical devices, Diabetes, FDA, Medicine, Membrane technology, Renal dialysis, Peritoneal dialysis, Dialysis, Kidney, Kt/V, Hemodialysis

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.S. clinical trial for the companys on-demand peritoneal dialysis (PD) solution generation system.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.S. clinical trial for the companys on-demand peritoneal dialysis (PD) solution generation system.
  • The system brings together Baxters pioneering innovations in home dialysis, industry-leading drug delivery technology and expertise in water filtration systems.
  • The on-demand technology uses a small water filtration device, concentrates and Baxters Amia automated peritoneal dialysis system to turn patients tap water into dialysis solution, as it is needed to complete each therapy session.
  • The clinical trial assesses the efficacy and safety of the system, with each participant using the new system for 12 weeks.